282 related articles for article (PubMed ID: 19591989)
1. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.
Luke B; Brown MB; Morbeck DE; Hudson SB; Coddington CC; Stern JE
Fertil Steril; 2010 Sep; 94(4):1399-1404. PubMed ID: 19591989
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
[TBL] [Abstract][Full Text] [Related]
3. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
5. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
Steward RG; Lan L; Shah AA; Yeh JS; Price TM; Goldfarb JM; Muasher SJ
Fertil Steril; 2014 Apr; 101(4):967-73. PubMed ID: 24462057
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
[TBL] [Abstract][Full Text] [Related]
7. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
Gera PS; Tatpati LL; Allemand MC; Wentworth MA; Coddington CC
Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.
Mourad S; Brown J; Farquhar C
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012103. PubMed ID: 28111738
[TBL] [Abstract][Full Text] [Related]
9. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
[TBL] [Abstract][Full Text] [Related]
10. Cabergoline for preventing ovarian hyperstimulation syndrome.
Tang H; Hunter T; Hu Y; Zhai SD; Sheng X; Hart RJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD008605. PubMed ID: 22336848
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.
Ho VNA; Braam SC; Pham TD; Mol BW; Vuong LN
Hum Reprod; 2019 Jun; 34(6):1055-1064. PubMed ID: 31111879
[TBL] [Abstract][Full Text] [Related]
12. Incidences and risk factors of moderate-to-severe ovarian hyperstimulation syndrome and severe hemoperitoneum in 1,435,108 oocyte retrievals.
Kuroda K; Nagai S; Ikemoto Y; Matsumura Y; Ochiai A; Nojiri S; Itakura A; Sugiyama R
Reprod Biomed Online; 2021 Jan; 42(1):125-132. PubMed ID: 33051135
[TBL] [Abstract][Full Text] [Related]
13. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
[TBL] [Abstract][Full Text] [Related]
14. Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.
Zhao J; Xu B; Huang X; Yan Y; Li Y
Reprod Health; 2020 Nov; 17(1):181. PubMed ID: 33218353
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.
Jiang X; Deng CY; Sun ZY; Chen WL; Wang HB; Zhou YZ; Jin L
Chin Med J (Engl); 2015 Dec; 128(23):3167-72. PubMed ID: 26612291
[TBL] [Abstract][Full Text] [Related]
16. Perinatal outcomes of singleton live births after late moderate-to-severe ovarian hyperstimulation syndrome: A propensity score-matched study.
Ran S; Zu R; Wu H; Zheng W; Yang C; Yang S; Ren B; Zhang W; Du J; Guan Y
Front Endocrinol (Lausanne); 2022; 13():1063066. PubMed ID: 36531504
[TBL] [Abstract][Full Text] [Related]
17. The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments.
Vainer-Rotbart S; Sheiner E; Harlev A; Bar G; Levy A
Am J Perinatol; 2023 Jul; 40(10):1088-1095. PubMed ID: 34327685
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a Cohort Study.
Jia Q; Fang L; Wang Z; Wu Z; Yan Y; Liu B; Cheng JC; Sun YP
Reprod Sci; 2021 Dec; 28(12):3341-3351. PubMed ID: 34081318
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
